Monographie - Levothyroxine - Stabilis 4.0

Last update :
27/11/2025

Hormone

Levothyroxine

injection

Oral solution

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Chemical structure

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

L-Thyroxin	Greece
L-Thyroxine	France
T4-Montpellier	Argentina
Thyradin S	Japan

References

injection

References : Levothyroxine

	Type	Publication
93	Journal	Hutchings SR, Rusho WJ, Tyler LS. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery. Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
2358	Journal	Das Gupta V. Stability of levothyroxine sodium injection in polypropylene syringes. Int J Pharm Compound 2000 ; 4, 6: 482-483.
3166	Journal	Strong DK, Decarie D, Ensom MHH. Stability of Levothyroxine in Sodium Chloride for IV Administration. Can J Hosp Pharm 2011 ; 63, 6: 437-443.
3228	Journal	Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers Am J Health-Syst Pharm 2011 ;68:1723-1728.
3879	Journal	Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures. Int J Pharm Compound 2016 ; 20, 4 : 328-332.
4465	Journal	Foushee A, Meredith P, Fox Laura, Wilder A. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients. Am J Health-Syst Pharm 2020 ;77,14:1144-1148
5021	Manufacturer	L-THYROXINE SERB 200 microgrammes/mL, solution injectable/pour perfusion - Résumé des caractéristiques du produit. SERB Laboratory 2025

Mentions Légales